跳到主要內容

Frazier Management LLC

SEC CIK
0001032165
最新申報
2022/11/14

2021 年第 3 季持倉

持倉截至 2021/9/30,2021/11/12 申報。只含多頭部位,變化是跟 2021 年第 2 季比股數。

機構總覽
持股檔數
41
較 2021 年第 2 季 +7
總值
$12.5 億
較 2021 年第 2 季 +$1.65 億 (+15.3%)
申報日
2021/11/12
SEC
Frazier Management LLC 在 2021 年第 3 季的持倉
證券類別股數市值佔組合 %股數變化動作紀錄
ARQTArcutis Biotherapeutics, Inc.COM8,434,232$2.01 億16.1%00.0%不變歷史
PHATPhathom Pharmaceuticals, Inc.COM5,827,415$1.87 億15.0%00.0%不變歷史
MIRMMirum Pharmaceuticals, Inc.COM3,566,912$7,105 萬5.7%00.0%不變歷史
IOVAIovance Biotherapeutics, Inc.COM2,674,299$6,595 萬5.3%+536,300+25.1%加碼歷史
IMGOImago BioSciences, Inc.COM2,971,274$5,952 萬4.8%+2,971,274新進歷史
PCVXVaxcyte, Inc.COM2,309,554$5,859 萬4.7%00.0%不變歷史
Trillium Therapeutics Inc.89620X506COM NEW3,123,107$5,498 萬4.4%00.0%不變–
GRTSGritstone bio, Inc.COM4,667,242$5,041 萬4.0%+3,636,364+352.7%加碼歷史
PASGPassage BIO, Inc.COM5,009,219$4,989 萬4.0%00.0%不變歷史
KRYSKrystal Biotech, Inc.COM771,250$4,027 萬3.2%−16,626−2.1%減碼歷史
TARSTarsus Pharmaceuticals, Inc.COM1,417,157$3,054 萬2.4%00.0%不變歷史
ISEEIVERIC bio, Inc.COM1,838,402$2,986 萬2.4%−706,098−27.7%減碼歷史
STROSutro Biopharma, Inc.COM1,468,663$2,774 萬2.2%+467,242+46.7%加碼歷史
VRDNViridian Therapeutics, Inc.COM1,505,200$2,476 萬2.0%+1,505,200新進歷史
ANABAnaptysbio, IncCOM899,700$2,440 萬2.0%00.0%不變歷史
AUTLAutolus Therapeutics plcSPON ADS3,530,657$2,313 萬1.9%+1,246,691+54.6%加碼歷史
SNDXSyndax Pharmaceuticals IncCOM1,188,135$2,271 萬1.8%00.0%不變歷史
TYRATyra Biosciences, Inc.COM1,250,000$2,199 萬1.8%+1,250,000新進歷史
KDNYChinook Therapeutics, Inc.COM1,671,918$2,133 萬1.7%+571,918+52.0%加碼歷史
ALPNAlpine Immune Sciences, Inc.COM1,771,844$1,891 萬1.5%−799,606−31.1%減碼歷史
BCYCBicycle Therapeutics PLCSPONSORED ADS442,880$1,842 萬1.5%+442,880新進歷史
CRNXCrinetics Pharmaceuticals, Inc.COM851,306$1,792 萬1.4%+851,306新進歷史
SRRASierra Oncology, Inc.COM NEW804,667$1,764 萬1.4%+601,864+296.8%加碼歷史
Frazier Lifesciences Acqu CoG3710A121UNIT 12/09/20251,501,000$1,506 萬1.2%00.0%不變–
REPLReplimune Group, Inc.COM491,998$1,458 萬1.2%+491,998新進歷史
Gracell Biotechnologies Inc38406L103SPONSORED ADS851,638$1,181 萬0.9%+851,638新進–
RGNXREGENXBIO Inc.COM235,809$988.5 萬0.8%−116,145−33.0%減碼歷史
AVDLAvadel Pharmaceuticals PLCSPONSORED ADR951,814$932.8 萬0.7%+373,710+64.6%加碼歷史
MTEMMolecular Templates, Inc.COM1,374,047$922.0 萬0.7%00.0%不變歷史
ACRSAclaris Therapeutics, Inc.COM408,329$735.0 萬0.6%+37,596+10.1%加碼歷史
SRRKScholar Rock Holding CorpCOM156,000$515.1 萬0.4%00.0%不變歷史
IMVTImmunovant, Inc.COM585,759$509.0 萬0.4%+331,759+130.6%加碼歷史
APTXAptinyx Inc.COM1,883,244$440.7 萬0.4%00.0%不變歷史
EPZMEpizyme, Inc.COM739,369$378.6 萬0.3%00.0%不變歷史
ALNAAllena Pharmaceuticals, Inc.COM3,330,373$300.5 萬0.2%00.0%不變歷史
EPIXESSA Pharma Inc.COM NEW358,346$286.7 萬0.2%+41,730+13.2%加碼歷史
KALVKalVista Pharmaceuticals, Inc.COM156,807$273.6 萬0.2%+156,807新進歷史
Bellus Health Inc New07987C204COM NEW433,247$264.9 萬0.2%−863,496−66.6%減碼–
GRTXGalera Therapeutics, Inc.COM241,000$195.2 萬0.2%00.0%不變歷史
Freeline Therapeutics Hldgs35655L107SPONSORED ADS550,000$187.6 萬0.2%00.0%不變–
Nabriva Therapeutics plcG63637113SHS425,650$50.7 萬<0.1%00.0%不變–

2021 年第 2 季之後清倉(1 檔)

2021 年第 2 季季末還持有、這份申報已經沒有的部位。

Frazier Management LLC 在 2021 年第 2 季之後清倉的部位
證券類別2021 年第 2 季股數2021 年第 2 季市值2021 年第 2 季佔組合 %紀錄
Translate Bio, Inc.89374L104COM2,082,789$5,736 萬5.3%–